BMN 673 (talazoparib)

talazoparib · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMN 673 (talazoparib), covering 2017-07-28 to 2017-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers [Phase 1]